Gainers
- Command Center, Inc. CCNI shares rose 35.2 percent to $5.30 in pre-market trading following news the company will merger in an all-stock deal with Hire Quest.
- PhaseBio Pharmaceuticals Inc PHAS rose 32 percent to $16.59 in pre-market trading after the company received FDA breakthrough therapy designation for PB2452 for the reversal of antiplatelet activity of ticagrelor.
- Adomani Inc ADOM rose 13.8 percent to $0.38 in pre-market trading following news company received initial orders from GerWeiss in Philippines. The order represents a sales opportunity of $1.7 million.
- TMSR Holding Company Limited TMSR rose 11.2 percent to $2.09 in pre-market trading. Coherus Biosciences said it expects UDENYCA preliminary unaudited net sales of $36.0 million to $38.0 million for the first quarter.
- T2 Biosystems, Inc. TTOO rose 10.3 percent to $3.42 in pre-market trading after surging 12.73 percent on Monday.
- NovoCure Limited NVCR rose 10 percent to $50.39 in pre-market trading.
- Celldex Therapeutics, Inc. CLDX shares rose 8.6 percent to $5.41 in pre-market trading after climbing 14.75 percent on Monday.
- Melinta Therapeutics, Inc. MLNT rose 8.3 percent to $5.35 in pre-market trading after gaining 15.15 percent on Monday.
- Laredo Petroleum, Inc. LPI rose 6.8 percent to $3.48 in pre-market trading after the company announced reduction of personnel costs by 25 percent. The company has reduced employee count by 20 percent.
- GW Pharmaceuticals plc GWPH rose 4.4 percent to $174.85 in pre-market trading in opposition to Zogenix shares. Following news Zogenix received a refusal to file letter from the FDA for its drug candidate to treat seizures related to Dravet Syndrome, traders may be viewing GW as a sympathy play.
- Alkermes plc ALKS rose 4 percent to $38.80 in pre-market trading after the company reported that its President and COO Jim Robinson will leave the company and ARISTADA trial met its primary endpoint.
- ICICI Bank Limited IBN rose 3.4 percent to $11.45 in pre-market trading.
- Avaya Holdings Corp. AVYA rose 3.3 percent to $18.33 in pre-market trading.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- Zogenix, Inc. ZGNX fell 28.6 percent to $37.03 in pre-market trading after the FDA sent a 'refusal to file letter' to the company for its new drug application for FINTEPLA. Guggenheim downgraded the stock from Buy to Neutral.
- Dare Bioscience Inc DARE fell 23.4 percent to $1.05 in pre-market trading after the company reported a proposed common stock offering.
- Zosano Pharma Corporation ZSAN fell 22.8 percent to $3.87 in pre-market trading following news of a common stock offering.
- SSLJ.com Limited SSLJ fell 13.3 percent to $2.60 in pre-market trading after rising 5.26 percent on Monday.
- Novartis AG NVS fell 10.1 percent to $85.32 in pre-market trading after the company spun off Alcon into an independent publicly traded company.
- Lindsay Corporation LNN shares fell 9.7 percent to $85.00 in pre-market trading after reporting downbeat Q2 results.
- Hollysys Automation Technologies Ltd. HOLI fell 7.6 percent to $21.49 in pre-market trading after reporting an offering of 7.8 million common share offering.
- Niu Technologies NIU fell 6.6 percent to $12.56 in pre-market trading after climbing 28.12 percent on Monday.
- Powerbridge Technologies Co., Ltd. PBTS fell 5.3 percent to $6.05 in pre-market trading after rising 3.40 percent on Monday.
- Ruth's Hospitality Group, Inc. RUTH fell 5.1 percent to $24.40 in pre-market trading.
- New Age Beverages Corporation NBEV fell 4.5 percent to $6.33 in pre-market trading after surging 38.56 percent on Monday.
- United States Steel Corporation X fell 4.5 percent to $18.86 in pre-market trading. Credit Suisse downgraded United States Steel from Neutral to Underperform and lowered the price target from $21 to $13.
- The Stars Group Inc. TSG fell 3.6 percent to $18.00 in pre-market trading.
- Homology Medicines Inc FIXX fell 3.6 percent to $28.50 in pre-market trading after reporting a $125 million common stock offering.
- Biohaven Pharmaceutical Holding Company Ltd. BHVN shares fell 3.5 percent to $48.50 in pre-market trading.
BHVNBiohaven Ltd
$39.17-%
CLDXCelldex Therapeutics Inc
$26.48-0.19%
DAREDare Bioscience Inc
$3.22-0.92%
IBNICICI Bank Ltd
$29.23-%
LNNLindsay Corp
$123.26-%
NIUNiu Technologies
$1.72-1.63%
NVCRNovoCure Ltd
$28.920.03%
NVSNovartis AG
$99.12-1.10%
TTOOT2 Biosystems Inc
$0.3501-2.78%
XUnited States Steel Corp
$32.990.64%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in